Search Results

5 Results for "noviosense".

Sort By

Drug Development

NovioSense Announces Positive Phase 2 Clinical Trial Results and the Commencement of a Second Follow Up Study

NovioSense has demonstrated the measurement of tear glucose in diabetic patients and the correlation to blood glucose with clinically relevant accuracy. The company announced the commencement of a second, 24-patient study, to validate the use of its tear glucose sensor in type 1 diabetic patients.

October 25, 2018
·
2 min read
NovioSense Announces Successful Clinical Trial And Secures 4th Round Financing For Its Tear Glucose Sensor

October 24, 2016
·
2 min read
Business

Gentag, Mayo Clinic, NovioSense And Fraunhofer Join Forces To Lower The Cost Of Diabetes Care Globally

July 14, 2015
·
1 min read
First Patent For NovioSense Non-Invasive Tear Glucose Sensor Issued In Europe

November 6, 2014
·
1 min read
Non-invasive Blood Glucose Monitoring Devices Market: Wearable segment dominated the global market in terms of revenue

Diabetes is a chronic disease that affects more than 8.5% of the global population. Monitoring the blood glucose levels on a regular basis is necessary to manage diabetes progression.

August 17, 2020
·
7 min read